ANSTO Nuclear Medicine Pty Ltd

Exporter · Australia

Nuclear Medicine Production and Distribution

About ANSTO Nuclear Medicine Pty Ltd

ANSTO Nuclear Medicine Pty Ltd (ANM) is a subsidiary of the Australian Nuclear Science and Technology Organisation (ANSTO), specializing in the production and distribution of nuclear medicines, particularly Molybdenum-99 (Mo-99), which decays to Technetium-99m (Tc-99m), a critical isotope used in approximately 80% of diagnostic nuclear medicine procedures. ANM operates facilities dedicated to manufacturing Mo-99 and utilizes innovative waste treatment technologies to support both domestic and international healthcare sectors. ANSTO Nuclear Medicine Pty Ltd (ANM) is a subsidiary of the Australian Nuclear Science and Technology Organisation (ANSTO), specializing in the production and distribution of nuclear medicines, particularly Molybdenum-99 (Mo-99), which decays to Technetium-99m (Tc-99m), a critical isotope used in approximately 80% of diagnostic nuclear medicine procedures. ANM operates facilities dedicated to manufacturing Mo-99 and utilizes innovative waste treatment technologies to support both domestic and international healthcare sectors. ANSTO ANSTO Company LinkedIn URL: Not Available